Skip Nav Destination
Targeted drugs in concert with chemo: opposites attract
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Issue Archive
May 7 2015
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
Targeted drugs in concert with chemo: opposites attract
Clinical Trials & Observations
PLENARY PAPER
TRANSPLANTATION
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat,Rohtesh S. Mehta,Katayoun Rezvani,Patricia Fox,Kayo Kondo,David Marin,Ian McNiece,Betul Oran,Chitra Hosing,Amanda Olson,Simrit Parmar,Nina Shah,Michael Andreeff,Partow Kebriaei,Indreshpal Kaur,Eric Yvon,Marcos de Lima,Laurence J. N. Cooper,Priti Tewari,Richard E. Champlin,Yago Nieto,Borje S. Andersson,Amin Alousi,Roy B. Jones,Muzaffar H. Qazilbash,Qaiser Bashir,Stefan Ciurea,Sairah Ahmed,Paolo Anderlini,Doyle Bosque,Catherine Bollard,Jeffrey J. Molldrem,Julianne Chen,Gabriela Rondon,Michael Thomas,Leonard Miller,Steve Wolpe,Paul Simmons,Simon Robinson,Patrick A. Zweidler-McKay,Elizabeth J. Shpall
BLOOD SPOTLIGHT
REVIEW ARTICLE
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia
Clinical Trials & Observations
Jennifer R. Brown,Jacqueline C. Barrientos,Paul M. Barr,Ian W. Flinn,Jan A. Burger,Anh Tran,Fong Clow,Danelle F. James,Thorsten Graef,Jonathan W. Friedberg,Kanti Rai,Susan O’Brien
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
Clinical Trials & Observations
Mike Dennis,Nigel Russell,Robert K. Hills,Claire Hemmaway,Nicki Panoskaltsis,Mary-Frances McMullin,Lars Kjeldsen,Helen Dignum,Ian F. Thomas,Richard E. Clark,Don Milligan,Alan K. Burnett
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL
Valeska Berg,Marion Rusch,Nachiket Vartak,Christian Jüngst,Astrid Schauss,Herbert Waldmann,Christian Hedberg,Christian P. Pallasch,Philippe I. H. Bastiaens,Michael Hallek,Clemens-Martin Wendtner,Lukas P. Frenzel
Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Brief Report
Saradhi Mallampati,Xiaohong Leng,Haiqing Ma,Jianfang Zeng,June Li,Haiying Wang,Kevin Lin,Yue Lu,Yang Yang,Baohua Sun,Yun Gong,Ju-Seog Lee,Marina Konopleva,Michael Andreeff,Ralph B. Arlinghaus,Zhen Cai,Bingliang Fang,Haifa Shen,Xin Han,Cheryl F. Hirsch-Ginsberg,Xiaolian Gao,Anurag N. Paranjape,Sendurai A. Mani,Karen Clise-Dwyer,Xiaoping Sun
MYELOID NEOPLASIA
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia
Clinical Trials & Observations
Andrea Kühnl,Peter J. M. Valk,Mathijs A. Sanders,Adam Ivey,Robert K. Hills,Ken I. Mills,Rosemary E. Gale,Martin F. Kaiser,Richard Dillon,Melanie Joannides,Amanda Gilkes,Torsten Haferlach,Susanne Schnittger,Estelle Duprez,David C. Linch,Ruud Delwel,Bob Löwenberg,Claudia D. Baldus,Ellen Solomon,Alan K. Burnett,David Grimwade
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
Clinical Trials & Observations
Yvonne V. Sanders,Dafna Groeneveld,Karina Meijer,Karin Fijnvandraat,Marjon H. Cnossen,Johanna G. van der Bom,M. Coppens,Joke de Meris,Britta A. P. Laros-van Gorkom,Eveline P. Mauser-Bunschoten,Frank W. G. Leebeek,Jeroen Eikenboom,the WiN study group
TRANSPLANTATION
α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice
Hidetaka Uryu,Daigo Hashimoto,Koji Kato,Eiko Hayase,Satomi Matsuoka,Reiki Ogasawara,Shuichiro Takahashi,Yoshinobu Maeda,Hiromi Iwasaki,Toshihiro Miyamoto,Shinobu Saijo,Yoichiro Iwakura,Geoffrey R. Hill,Koichi Akashi,Takanori Teshima
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Clinical Trials & Observations
Shannon R. McCurdy,Jennifer A. Kanakry,Margaret M. Showel,Hua-Ling Tsai,Javier Bolaños-Meade,Gary L. Rosner,Christopher G. Kanakry,Karlo Perica,Heather J. Symons,Robert A. Brodsky,Douglas E. Gladstone,Carol Ann Huff,Keith W. Pratz,Gabrielle T. Prince,Amy E. Dezern,Ivana Gojo,William H. Matsui,Ivan Borrello,Michael A. McDevitt,Lode J. Swinnen,B. Douglas Smith,Mark J. Levis,Richard F. Ambinder,Leo Luznik,Richard J. Jones,Ephraim J. Fuchs,Yvette L. Kasamon
BLOOD WORK
CORRESPONDENCE
ERRATA
-
Cover Image
Cover Image
Expression of mCherry-coupled APT1 in HeLa cells (confocal microscopy, 63-fold magnification). See the article by Berg et al on page 2948.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals